Vesicular stomatitis virus matrix protein gene enhances the antitumor effects of radiation via induction of apoptosis

Shao R, Karunagaran D, Zhou BP, Li K, Lo SS, Deng J et al (1997) Inhibition of nuclear factor-B activity is involved in E1A-mediated sensitization of radiation-induced apoptosis. J Biol Chem 272:32739–32742. doi:10.1074/jbc.272.52.32739 Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL et al (2000) Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci USA 97:1754–1759. doi:10.1073/pnas.030545097 Tenzer A, Zingg D, Rocha S, Hemmings B, Fabbro D, Glanzmann C et al (2001) The phosphatidylinositide 3-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C. Cancer Res 61:8203–8210 Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304–6311 Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847–849. doi:10.1038/362847a0 Nagasawa H, Li CY, Maki CG, Imrich AC, Little JB (1995) Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells. Cancer Res 55:1842–1846 Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ et al (1996) Retrovirusmediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 2:985–991. doi:10.1038/nm0996-985 Gallardo D, Drazan KE, McBride WH (1996) Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity. Cancer Res 56:4891–4893 Li JH, Lax SA, Kim J, Klamut H, Li FF (1999) The effects of ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 43:607–616. doi:10.1016/S0360-3016(98)00432-5 Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N et al (2000) Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 6:821–825. doi:10.1038/77558 Balachandran S, Porosnic M, Barber GN (2001) Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, ras, or myc function and involves the induction of apoptosis. J Virol 75:3474–3479. doi:10.1128/JVI.75.7.3474-3479.2001 Shinozaki K, Ebert O, Kournioti C, Tai YS, Woo SL (2004) Oncolysis of multifocal hepatocellular carcinoma in the rat liver by hepatic artery infusion of vesicular stomatitis virus. Mol Ther 9:368–376. doi:10.1016/j.ymthe.2003.12.004 Li Q, Wei YQ, Wen YJ, Zhao Xia, Tian Ling, Yang Li et al (2004) Induction of apoptosis and tumor regression by vesicular stomatitis virus in the presence of gemcitabine in lung cancer. Int J Cancer 20:143–149. doi:10.1002/ijc.20276 Ebert O, Shinozaki K, Kournioti C, Park MS, Garcia-Sastre A, Woo SL (2004) Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer. Cancer Res 1:3265–3270. doi:10.1158/0008-5472.CAN-03-3753 Ebert O, Harbaran S, Shinozaki K, Woo SL (2005) Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice. Cancer Gene Ther 2:350–358. doi:10.1038/sj.cgt.7700794 Ahmed M, Lyles DS (1998) Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III. J Virol 2:8413–8419 Black BL, Lyles DS (1992) Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J Virol 66:4058–4064 Black BL, Rhodes RB, McKenzie M, Lyles DS (1993) The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly. J Virol 67:4814–4821 Ferran MC, Lucas-Lenard JM (1997) The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J Virol 71:371–377 Lin X, Chen X, Wei Y, Zhao J, Fan L, Wen Y et al (2007) Efficient inhibition of intraperitoneal human ovarian cancer growth and prolonged survival by gene transfer of vesicular stomatitis virus matrix protein in nude mice. Gynecol Oncol 104:540–546. doi:10.1016/j.ygyno.2006.09.022 Zhang H, Wen Y, Mao B, Gong Q, Qian Z, Wei Y (2007) Plasmid encoding matrix protein of vesicular stomatitis viruses as an antitumor agent inhibiting rat glioma growth in situ. Exp Oncol 29:85–93 Zhao JM, Liu T, Xu JR, Wang GQ, Du XB, Wen YJ (2007) Effects of vesicular stomatitis virus matrix protein on proliferation and apoptosis of mouse LL/2c cells. Ai Zheng 26:230–235 Wei Y-Q, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A (1994) Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res 54:4952–4957 Nguyen JT, Wells JA (2003) Direct activation of the apoptosis machinery as a mechanism to target cancer cells. Proc Natl Acad Sci USA 100:7533–7538. doi:10.1073/pnas.1031631100 Eastman A, Rigas JR (1999) Modulation of apoptosis signaling pathways and cell cycle regulation. Semin Oncol 26:7–16 Paik SY, Banerjea AC, Harmison GG, Chen CJ, Schubert M (1995) Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein. J Virol 69:3529–3537 Kopecky SA, Lyles DS (2003) Contrasting effects of matrix protein on apoptosis in HeLa and BHK cells infected with vesicular stomatitis virus are due to inhibition of host gene expression. J Virol 77:4658–4669. doi:10.1128/JVI.77.8.4658-4669.2003 Kopecky SA, Lyles DS (2003) The cell-rounding activity of the vesicular stomatitis virus MatrixProtein is due to the induction of cell death. J Virol 77:5524–5528. doi:10.1128/JVI.77.9.5524-5528.2003 Lyles DS, McKenzie MO (1997) Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function. Virology 229:77–89. doi:10.1006/viro.1996.8415 Her LS, Lund E, Dahlberg JE (1997) Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science 276:1845–1848. doi:10.1126/science.276.5320.1845 Petersen JM, Her L, Varvel V, Lund E, Dahlberg JE (2000) The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol Cell Biol 20:8590–8601. doi:10.1128/MCB.20.22.8590-8601.2000 von Kobbe C, van Deursen JM, Rodrigues JP, Sitterlin D, Bachi A, Wu X et al (2000) Vesicular stomatitis virus matrix protein inhibits host cellgene expression by targeting the nucleoporin nup98. Mol Cell 6:1243–1252. doi:10.1016/S1097-2765(00)00120-9 Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7:683–694. doi:10.1016/S1097-2765(01)00214-3 Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T et al (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-inducedapoptosis. Science 288:1053–1058. doi:10.1126/science.288.5468.1053 Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ et al (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727–730. doi:10.1126/science.1059108 Haimovitz-Friedman A, Kan CC, Ehleiter D (1994) Ionizing radiation acts on cellularmembranes to generate ceramide and initiate apoptosis. J Exp Med 180:525–535. doi:10.1084/jem.180.2.525 Zhivotovsky B, Joseph B, Orrenius S (1999) Tumor radiosensitivityand apoptosis. Exp Cell Res 248:10–17. doi:10.1006/excr.1999.4452 Li Shiyong, Yu Bo, An Ping, Chen Gang, Lu Wenping, Cai Huiyun et al (2005) Combined liposome-mediated cytosine deaminase gene therapy with radiation in killing rectal cancer cells and xenografts in athymic mice. Clin Cancer Res 11:3574–3578. doi:10.1158/1078-0432.CCR-04-2077 Patijn GA, Lieber A, Meuse L, Winther B, Kay MA (1998) High-efficiency retrovirus-mediated gene transfer into the livers of mice. Hum Gene Ther 9:1449–1456. doi:10.1089/hum.1998.9.10-1449 Li S, Rizzo MA, Bhattacharya S, Huang L (1998) Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther 5:930–937. doi:10.1038/sj.gt.3300683 Tan Y, Li S, Pitt BR, Huang L (1999) The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector mediated transgene expression in vivo. Hum Gene Ther 10:2153–2161. doi:10.1089/10430349950017149 Megyeri K, Orosz L, Kemény L (2007) Vesicular stomatitis virus infection triggers apoptosis associated with decreased DeltaNp63alpha and increased Bax levels in the immortalized HaCaT keratinocyte cell line. Biomed Pharmacother 61:254–260. doi:10.1016/j.biopha.2007.03.006 Ito I, Began G, Mohiuddin I, Saeki T, Saito Y, Branch CD et al (2003) Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration. Mol Ther 7:409–418. doi:10.1016/S1525-0016(03)00004-2 Kevin C, Moses MA, Beecken W-D, Khan MK, Folkman J, O’Reilly MS (2001) Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 61:2207–2211